TSOI — Therapeutic Solutions International Share Price
0.000.00%
Last trade - 00:00- $2.96m
- $3.63m
- $0.21m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.26 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 35.36 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -147.98% | ||
| Return on Equity | -173.33% | ||
| Operating Margin | -2511.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0 | 0.03 | 0.06 | 0.15 | 0.21 | n/a | n/a | 135.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury, and for daily health. The Company's flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. The Company also sells certain nutraceuticals. The Company has also developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells.
Directors
- Timothy Dixon CHM (62)
- Feng Lin CSO (51)
- Famela Ramos VBD (44)
- James Veltmeyer OTH (56)
- Thomas Ichim DRC (44)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- August 6th, 2007
- Public Since
- June 9th, 2008
- No. of Employees
- 3
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 4,230,116,869
- Address
- 701 Wild Rose Lane, ELK CITY, 83525
- Web
- https://therapeuticsolutionsint.com/
- Phone
- +1 7602957208
- Auditors
- Fruci & Associates II,PLLC
Upcoming Events for TSOI
Q2 2024 Therapeutic Solutions International Inc Earnings Release
Similar to TSOI
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
What is the Therapeutic Solutions International share price?
As of Today at 19:21 UTC, shares in Therapeutic Solutions International are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Therapeutic Solutions International share price performed this year?
Shares in Therapeutic Solutions International last closed at $0.00 and the price had moved by -83.33% over the past 365 days. In terms of relative price strength the Therapeutic Solutions International share price has underperformed the S&P500 Index by -85.3% over the past year.
What are the analyst and broker recommendations for Therapeutic Solutions International?
There is no consensus recommendation for this security.
What is the Therapeutic Solutions International dividend yield?
Therapeutic Solutions International does not currently pay a dividend.
Does Therapeutic Solutions International pay a dividend?
Therapeutic Solutions International does not currently pay a dividend.
When does Therapeutic Solutions International next pay dividends?
Therapeutic Solutions International does not currently pay a dividend.
How do I buy Therapeutic Solutions International shares?
To buy shares in Therapeutic Solutions International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Therapeutic Solutions International?
As of the previous close price of $0.00, shares in Therapeutic Solutions International had a market capitalisation of $2.96m.
Where are Therapeutic Solutions International shares listed?
Here are the trading details for Therapeutic Solutions International:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TSOI
What kind of share is Therapeutic Solutions International?
Based on an overall assessment of its quality, value and momentum Therapeutic Solutions International is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Therapeutic Solutions International share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Therapeutic Solutions International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Therapeutic Solutions International. Over the past six months, its share price has underperformed the S&P500 Index by -59.77%.
As of the last closing price of $0.00, shares in Therapeutic Solutions International were trading -46.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Therapeutic Solutions International PE Ratio?
The Therapeutic Solutions International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Therapeutic Solutions International?
Therapeutic Solutions International's management team is headed by:
- Timothy Dixon - CHM
- Feng Lin - CSO
- Famela Ramos - VBD
- James Veltmeyer - OTH
- Thomas Ichim - DRC